Furthermore, our findings underscore the importance of considering AQP4-IgG testing and comprehensive MRI evaluation in patients with MDD or BD who present with mild neurological symptoms in psychiatric settings, such as vomiting or visual impairment. Here, AQP4 is linked to major depressive disorder.